These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 8409060)

  • 1. Safety and efficacy of a new transpulmonary echo contrast agent in echocardiographic studies in patients.
    Geny B; Mettauer B; Muan B; Bischoff P; Epailly E; Piquard F; Eisenmann B; Haberey P
    J Am Coll Cardiol; 1993 Oct; 22(4):1193-8. PubMed ID: 8409060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of Albunex on the pulmonary circulation in patients with pulmonary hypertension or left heart failure.
    Zotz RJ; Genth S; Mitrovic V; Waaler A; Erbel R; Meyer J
    Eur Heart J; 1996 Feb; 17(2):302-7. PubMed ID: 8732386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic characteristics, myocardial kinetics and microvascular rheology of FS-069, a second-generation echocardiographic contrast agent capable of producing myocardial opacification from a venous injection.
    Skyba DM; Camarano G; Goodman NC; Price RJ; Skalak TC; Kaul S
    J Am Coll Cardiol; 1996 Nov; 28(5):1292-300. PubMed ID: 8890829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast echocardiography in coronary artery diseased patients: effect of systemic and pulmonary artery pressures on left heart opacification after intravenous injection of Albunex.
    Geny B; Piquard F; Muan B; Epailly E; Lambrechs M; Thiranos JC; Petit H; Eisenmann B; Haberey P
    Coron Artery Dis; 1997 Feb; 8(2):77-81. PubMed ID: 9211046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left ventricular opacification by intravenous contrast echocardiography.
    Castini D; Gentile F; Ornaghi M; Mangiarotti E; Garbin M; Ravaglia R; Gioventù M; Mantero A; Corno R; Limido A; Morandi F; Fiorentini C; Pezzano A; Repetto S; Haider T; Morris H; Marelli C
    G Ital Cardiol; 1999 Jun; 29(6):620-9. PubMed ID: 10396665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of a new transpulmonary echocontrast agent (Albunex) in repeated echocardiographic studies in patients.
    Geny B; Bischoff P; Muan B; Piquard F; Thiranos JC; Epailly E; Lambrechs M; Juelsrud-Vebner A; Eisenmann B; Haberey P
    Clin Cardiol; 1997 Feb; 20(2):111-5. PubMed ID: 9034639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of a new intravenous echo contrast agent (BY 963) with Albunex for opacification of left ventricular cavity.
    Leischik R; Beller KD; Erbel R
    Basic Res Cardiol; 1996; 91(1):101-9. PubMed ID: 8660247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of intravenous Albunex injections on pulmonary arterial pressure, gas exchange, and left ventricular peak intensity.
    Walker R; Wiencek JG; Aronson S; Zaroff J; Glock D; Thisted R; Feinstein SB
    J Am Soc Echocardiogr; 1992; 5(5):463-70. PubMed ID: 1389214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracoronary albunex. Its effects on left ventricular hemodynamics, function, and coronary sinus flow in humans.
    Ten Cate FJ; Widimsky P; Cornel JH; Waldstein DJ; Serruys PW; Waaler A
    Circulation; 1993 Nov; 88(5 Pt 1):2123-7. PubMed ID: 8222106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intrapulmonary arterial injection of Albunex for left heart contrast echocardiography].
    Fukui O; Lim YJ; Nakatani D; Kawano S; Kodama K; Masuyama T; Asanuma H; Hori M; Mishima M
    J Cardiol; 1998 Feb; 31(2):99-107. PubMed ID: 9513037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Albunex: a safe and effective commercially produced agent for myocardial contrast echocardiography.
    Keller MW; Glasheen W; Kaul S
    J Am Soc Echocardiogr; 1989; 2(1):48-52. PubMed ID: 2627424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast opacification of left ventricular myocardium following intravenous administration of sonicated albumin microspheres.
    Sanders WE; Cheirif J; Desir R; Zoghbi WA; Hoyt BD; Schulz PE; Quiñones MA
    Am Heart J; 1991 Dec; 122(6):1660-5. PubMed ID: 1957761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced forward output states affect the left ventricular opacification of intravenously administered Albunex.
    Gandhok NK; Block R; Ostoic T; Rawal M; Hickle P; Devries S; Feinstein SB
    J Am Soc Echocardiogr; 1997; 10(1):25-30. PubMed ID: 9046490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of a new transpulmonary ultrasound contrast agent: initial multicenter clinical results.
    Feinstein SB; Cheirif J; Ten Cate FJ; Silverman PR; Heidenreich PA; Dick C; Desir RM; Armstrong WF; Quinones MA; Shah PM
    J Am Coll Cardiol; 1990 Aug; 16(2):316-24. PubMed ID: 2197312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent. Results of a phase III Multicenter Trial.
    Cohen JL; Cheirif J; Segar DS; Gillam LD; Gottdiener JS; Hausnerova E; Bruns DE
    J Am Coll Cardiol; 1998 Sep; 32(3):746-52. PubMed ID: 9741522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial imaging with a new transpulmonary lipid-fluorocarbon echo contrast agent: experimental studies in pigs.
    Grauer SE; Pantely GA; Xu J; Ge S; Giraud GD; Shiota T; Sahn DJ
    Am Heart J; 1996 Nov; 132(5):938-45. PubMed ID: 8892764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial contrast enhancement after intravenous injection of sonicated albumin microbubbles: a transesophageal echocardiography dipyridamole study.
    Voci P; Bilotta F; Merialdo P; Agati L
    J Am Soc Echocardiogr; 1994; 7(4):337-46. PubMed ID: 7917341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of QW7437, a new fluorocarbon-based echocardiographic contrast agent.
    Main ML; Escobar JF; Hall SA; Grayburn PA
    J Am Soc Echocardiogr; 1997 Oct; 10(8):798-804. PubMed ID: 9356943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Improved left ventricular endocardial detection by a first generation contrast agent. Effect of dose].
    Vargas F; Hilbert G; Gruson D; Chene G; Journot V; Diebold B; Roudaut R
    Arch Mal Coeur Vaiss; 2000 Jan; 93(1):41-7. PubMed ID: 11227717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opacification and border delineation improvement in patients with suboptimal endocardial border definition in routine echocardiography: results of the Phase III Albunex Multicenter Trial.
    Crouse LJ; Cheirif J; Hanly DE; Kisslo JA; Labovitz AJ; Raichlen JS; Schutz RW; Shah PM; Smith MD
    J Am Coll Cardiol; 1993 Nov; 22(5):1494-500. PubMed ID: 8227810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.